Markets

  1. Home
Market Nav

News Details

12/01/2026 12:08

Alembic Pharmaceutic - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Alembic Pharmaceuticals Limited announces USFDA Tentative approval for Bosutinib Tablets, 400 mg.